Abstract
Three-dimensional quantitative structure-activity relationship was developed for the series of compounds as malonyl-CoA decarboxylase antagonists (MCD) using the CoMFA and CoMSIA methods. The statistical parameters for CoMFA (q2=0.558, r2=0.841) and CoMSIA (q2= 0.615, r2 = 0.870) models were derived based on 38 compounds as training set in the basis of the selected alignment. The external predictive abilities of the built models were evaluated by using the test set of nine compounds. From obtained results, the CoMSIA method was found to have highly predictive capability in comparison with CoMFA method. Based on the given results by CoMSIA and CoMFA contour maps, some features that can enhance the activity of compounds as MCD antagonists were introduced and used to design new compounds with better inhibition activity.
Keywords: 3D-QSAR, chemometrics, CoMSIA, drug design, malonyl-CoA decarboxylase.
Combinatorial Chemistry & High Throughput Screening
Title:3D-QSAR analysis of MCD inhibitors by CoMFA and CoMSIA
Volume: 18 Issue: 8
Author(s): Eslam Pourbasheer, Reza Aalizadeh, Amin Ebadi and Mohammad Reza Ganjali
Affiliation:
Keywords: 3D-QSAR, chemometrics, CoMSIA, drug design, malonyl-CoA decarboxylase.
Abstract: Three-dimensional quantitative structure-activity relationship was developed for the series of compounds as malonyl-CoA decarboxylase antagonists (MCD) using the CoMFA and CoMSIA methods. The statistical parameters for CoMFA (q2=0.558, r2=0.841) and CoMSIA (q2= 0.615, r2 = 0.870) models were derived based on 38 compounds as training set in the basis of the selected alignment. The external predictive abilities of the built models were evaluated by using the test set of nine compounds. From obtained results, the CoMSIA method was found to have highly predictive capability in comparison with CoMFA method. Based on the given results by CoMSIA and CoMFA contour maps, some features that can enhance the activity of compounds as MCD antagonists were introduced and used to design new compounds with better inhibition activity.
Export Options
About this article
Cite this article as:
Pourbasheer Eslam, Aalizadeh Reza, Ebadi Amin and Ganjali Reza Mohammad, 3D-QSAR analysis of MCD inhibitors by CoMFA and CoMSIA, Combinatorial Chemistry & High Throughput Screening 2015; 18 (8) . https://dx.doi.org/10.2174/1386207318666150803141738
DOI https://dx.doi.org/10.2174/1386207318666150803141738 |
Print ISSN 1386-2073 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5402 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Antioxidant Therapy Against Trypanosome Infections: A Review Update
Current Topics in Medicinal Chemistry Incretin-based Therapies for Type 2 Diabetes Mellitus: Effects on Insulin Resistance
Current Diabetes Reviews Targeting Dyslipidemia in the Metabolic Syndrome: An Update
Current Vascular Pharmacology Clinical Observation of Liver Chemistry Abnormalities in Asthmatics
Current Drug Safety Agave (Agave spp.) and its Traditional Products as a Source of Bioactive Compounds
Current Bioactive Compounds Role of Statins in Diabetes Complications
Current Diabetes Reviews The Role of Platelets in Cardiovascular Disease: Molecular Mechanisms
Current Pharmaceutical Design The Relationship between Findings of the Cardiopulmonary Exercise Test and the Functional Class in Patients with Advanced Heart Failure Candidate for Heart Transplantation
Current Respiratory Medicine Reviews Effects of Coronary Computer Tomography Angiography Screening on Smoking Habits in Asymptomatic Individuals with Family History of Premature Coronary Heart Disease
New Emirates Medical Journal Recent Advances of Fluorescent Technologies for Drug Discovery and Development
Current Pharmaceutical Design Treating High Density Lipoprotein Cholesterol (HDL-C): Quantity Versus Quality
Current Pharmaceutical Design Insulin Resistance is Associated with Subclinical Vascular Injury in Patients with a Kidney Disease
Current Cardiology Reviews Comparison of Biolimus Versus Everolimus for Drug-Eluting Stents in the Percutaneous Treatment of Infra-Inguinal Arterial Disease
Current Vascular Pharmacology Obesity-Associated Hypertension in Childhood: A New Epidemic Problem
Current Hypertension Reviews The Connection Between C-Reactive Protein (CRP) and Diabetic Vasculopathy. Focus on Preclinical Findings
Current Diabetes Reviews Inflammatory Biomarkers, Depressive Symptoms and Falls Among the elderly in Panama
Current Aging Science Application of Mesenchymal Stem Cells to Age-related Neuronal Diseases
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Oleanolic Acid and Related Triterpenoids from Olives on Vascular Function: Molecular Mechanisms and Therapeutic Perspectives
Current Medicinal Chemistry Lipoprotein(a) Management: Pharmacological and Apheretic Treatment
Current Medicinal Chemistry Side Effects of AAS Abuse: An Overview
Mini-Reviews in Medicinal Chemistry